Drug level testing as a strategy to determine eligibility for drug resistance testing after failure of ART: a retrospective analysis of South African adult patients on second‐line ART-Reference-Cited by-同舟云学术

Drug level testing as a strategy to determine eligibility for drug resistance testing after failure of ART: a retrospective analysis of South African adult patients on second‐line ART

Published:2020-06 Issue:6 Volume:23 Page:
ISSN:1758-2652
Container-title:Journal of the International AIDS Society
language:en
Short-container-title:J Intern AIDS Soc

Author:

Hermans Lucas E¹²³^ORCID,Steegen Kim⁴⁵,Heine Rob⁶,Schuurman Rob¹,Tempelman Hugo A²³,Moraba Robert³,Maarseveen Erik⁷,Nijhuis Monique¹²³,Pillay Taryn⁸⁹,Legg‐E’Silva Derryn⁸⁹,Snyman Tracy⁸⁹,Schapiro Jonathan M¹⁰,Burger David M⁶,Carmona Sergio⁴⁵,Wensing Annemarie MJ¹²³^ORCID

Affiliation:

1. Virology Department of Medical Microbiology University Medical Center Utrecht (UMCU) Utrecht The Netherlands

2. Wits Reproductive Health and HIV Institute (Wits RHI) University of the Witwatersrand Johannesburg South Africa

3. Ndlovu Research Consortium Elandsdoorn South Africa

4. Department of Molecular Medicine and Haematology Faculty of Health Sciences University of the Witwatersrand Johannesburg South Africa

5. Department of Molecular Medicine and Haematology National Health Laboratory Service (NHLS) Johannesburg South Africa

6. Department of Pharmacy Radboud Institute for Health Sciences Radboud University Medical Center Nijmegen The Netherlands

7. Clinical Pharmacology UMCU The Netherlands

8. Department of Chemistry University of the Witwatersrand Johannesburg South Africa

9. National Health Laboratory Service (NHLS) Johannesburg South Africa

10. National Hemophilia Center Sheba Medical Center Ramat Gan Israel

Funder

The Netherlands Organisation for Health Research and Development (ZonMW) and NWO-WOTRO Science for Global Development

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jia2.25501

Reference38 articles.

1. Long-term Virological Outcomes of First-Line Antiretroviral Therapy for HIV-1 in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis

2. Virological suppression and clinical management in response to viremia in South African HIV treatment program: A multicenter cohort study

3. World Health Organization.Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection.2016. Available from:https://www.who.int/hiv/pub/arv/arv‐2016/en/. Accessed May 10 2020.

4. Clinton Health Access Initiative. HIV Market Report.2019. Available from:https://3cdmh310dov3470e6x160esb‐wpengine.netdna‐ssl.com/wp‐content/uploads/2019/12/2019‐HIVMarket‐Report.pdf. Accessed May 10 2020.

5. Sustained Virological Response on Second-Line Antiretroviral Therapy following Virological Failure in HIV-Infected Patients in Rural South Africa

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV-1 drug resistance and genetic diversity in people with HIV-1 in Cape Verde;AIDS;2024-02-12

2. “I feel drug resistance testing allowed us to make an informed decision”: qualitative insights on the role of HIV drug resistance mutation testing among children and pregnant women living with HIV in western Kenya;BMC Health Services Research;2023-08-24

3. Advancing HIV Drug Resistance Technologies and Strategies: Insights from South Africa’s Experience and Future Directions for Resource-Limited Settings;Diagnostics;2023-06-29

4. Point-of-care urine tenofovir testing to predict HIV drug resistance among individuals with virologic failure;AIDS;2023-02-16

5. A randomized study of intensified antiretroviral treatment monitoring versus standard-of-care for prevention of drug resistance and antiretroviral treatment switch;AIDS;2022-10-04